Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions

American Journal of Human Genetics

Volumn 69, Issue 3, 2001, Pages 493-503

  Niida, Yo ^a,b   Stemmer Rachamimov, Anat O ^a   Logrip, Marian ^a   Tapon, Dagmar ^a   Perez, Ronald ^c   Kwiatkowski, David J ^c   Sims, Katherine ^a   MacCollin, Mia ^a   Louis, David N ^a   Ramesh, Vijaya ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; HAMARTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; SOMATIC MUTATION; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE;

EID: 0034887907     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/321972     Document Type: Article

References (50)

1. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation
2. Loss of the TSC2 product tuberin in subependymal giant-cell tumors
3. Complete inactivation of the TSC2 gene leads to formation of hamartomas
4. Germline mutational analysis of the TSC2 gene in 90 tuberous sclerosis patients
5. Exon scanning of the entire TSC2 gene for germline mutations in 40 unrelated patients with tuberous sclerosis
6. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene
7. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis
8. Molecular genetic advances in tuberous sclerosis
9. Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2
10. NF1 tumor suppressor gene function: Narrowing the GAP
11. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs
12. Pten is essential for embryonic development and tumor suppression
13. Identification and characterization of the tuberous sclerosis gene on chromosome 16
14. kip1 is haplo-insufficient for tumor suppression
15. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor
16. Clonality of tuberous sclerosis harmatomas shown by non-random X-chromosome inactivation
17. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions
18. Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors
19. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo
20. Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis
21. Comprehensive mutation analysis of TSC1 and TSC2 - And phenotypic correlations in 150 families with tuberous sclerosis
22. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis
23. Identification of a leader exon and a core promoter for the rat tuberous sclerosis 2 (Tsc2) gene and structural comparison with the human homolog
24. Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease
25. Early detection of Knudson's two-hits in preneoplastic renal cells of the Eker rat model by laser microdissection procedure
26. Allelic loss at the predisposing gene locus in spontaneous and chemically induced renal cell carcinomas in the Eker rat
27. A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens
28. Tumor suppressor genes
29. Comparative analysis and genomic structure of the tuberous sclerosis 2 (TSC2) gene in human and pufferfish
30. Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation
31. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
32. Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis
33. Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney
34. Characterization of the cytosolic tuberin-hamartin complex: Tuberin is a cytosolic chaperone for hamartin
35. Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis
36. Expression and differential splicing of the mouse TSC2 homolog
37. +/- mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background
38. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas
39. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles
40. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
41. Somatic inactivation of the VHL gene in von Hippel-Lindau disease tumors
42. Tuberous sclerosis complex consensus conference: Revised clinical diagnostic criteria
43. Loss of heterozygosity in tuberous sclerosis hamartomas
44. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34
45. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products
46. Retention of wild-type p53 in tumors from p53 heterozygous mice: Reduction of p53 dosage can promote cancer formation
47. Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of transheterozygous mutations
48. Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues
49. Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat
50. Analysis of meningiomas by methylation and transcription-based clonality assays